Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Buy
71
SLNO Quote, Financials, Valuation and Earnings
Last price:
$67.30
Seasonality move
:
8.1%
Day range:
$62.11 - $67.37
52-week range:
$36.61 - $74.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3,450.85x
P/B ratio:
12.58x
Volume:
985.4K
Avg. volume:
1.9M
1-year change:
72.43%
Market cap:
$3.1B
Revenue:
--
EPS (TTM):
-$4.26
Earnings Data
Next earnings date for SLNO
Aug 07
2025
Most recent earnings per share
-$1.27
Missed by $1.27
(Feb 27/2025)
Consensus Estimate
--
(Feb 27/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SLNO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/07/2025 | Q2 | $2.8M | -- | -- | -- | -- |
| 03/31/2025 | Q1 | -- | -- | -- | -- | -- |
| 02/27/2025 | Q4 | -- | -- | -$1.27 | -- | -- |
| 11/06/2024 | Q3 | -- | -- | -$1.83 | -- | -- |
| 08/07/2024 | Q2 | -- | -- | -$0.57 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.59 | -- | -- |
| 03/21/2024 | Q4 | -- | -- | -$0.36 | -- | -- |
| 11/08/2023 | Q3 | -- | -- | -$0.95 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.81 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.88 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.58 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.65 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.72 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.07 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.53 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$1.53 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$2.10 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$1.65 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.60 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$1.65 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$2.40 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$1.95 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$5.40 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$2.85 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$4.65 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$3.30 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | $0.15 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$1.95 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$5.25 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$2.85 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$6.00 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$5.85 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$6.30 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$8.55 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$29.85 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$13.05 | -- | -- |
| 06/30/2016 | Q2 | -- | $2K | -$17.25 | -- | -- |
| 03/31/2016 | Q1 | -- | $447K | -$16.50 | -- | -- |
| 12/31/2015 | Q4 | -- | $241.6K | -$6.75 | -- | -- |
| 09/30/2015 | Q3 | -- | $92K | -$24.75 | -- | -- |
| 06/30/2015 | Q2 | -- | $97K | $18.75 | -- | -- |
Soleno Therapeutics Earnings Questions
-
How Much did Soleno Therapeutics Generate in Revenue Last Quarter?
Soleno Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Soleno Therapeutics Beat Earnings Last Quarter?
Soleno Therapeutics announced earnings per share of -$1.27 which represents a miss of analyst forecast a -- per share.
-
Is Soleno Therapeutics Profitable?
Soleno Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Soleno Therapeutics EPS Next Year?
Soleno Therapeutics's earnings are forecast to grow from -$4.38 per share to -- per share next year representing an increase of --.
-
When is Soleno Therapeutics's Earnings Date?
Soleno Therapeutics's next earnings date is August 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
